The total return over the past 12 months is -92.40% vs. +16.94% for the S&P 500. So far it's up -90.46% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (92.44%) | (62.11%) | (61.48%) | (68.99%) | N/A | N/A |
| Total Return CAGR | (92.40%) | (62.03%) | (61.44%) | (68.97%) | N/A | N/A |
| Revenue CAGR | (8.47%) | +38.35% | +38.99% | (2.33%) | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
BioRestorative Therapies, Inc. (BRTX)
| Year | Start price | End price | BRTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $23.60 | $2.24 | (90.46%) | +14.51% | (104.97%) |
| 2025 | $28.60 | $23.60 | (17.46%) | +17.72% | (35.18%) |
| 2024 | $34.80 | $28.60 | (17.81%) | +24.89% | (42.70%) |
| 2023 | $55.00 | $34.80 | (36.73%) | +26.19% | (62.92%) |
| 2022 | $86.80 | $55.00 | (36.66%) | (18.17%) | (18.49%) |
| 2021 | $552.00 | $86.80 | (84.27%) | +28.74% | (113.01%) |
| 2020 | $400.00 | $552.00 | +38.00% | +18.37% | +19.63% |
| 2019 | $72,000.00 | $400.00 | (99.44%) | +31.22% | (130.66%) |
| 2018 | $296,000.00 | $72,000.00 | (75.68%) | (4.56%) | (71.12%) |
| 2017 | $264,000.00 | $296,000.00 | +12.12% | +21.70% | (9.58%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
